Naomi S. Sprigg

2.1k total citations · 2 hit papers
11 papers, 1.7k citations indexed

About

Naomi S. Sprigg is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Naomi S. Sprigg has authored 11 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Naomi S. Sprigg's work include Cytokine Signaling Pathways and Interactions (6 papers), interferon and immune responses (3 papers) and Immune Cell Function and Interaction (3 papers). Naomi S. Sprigg is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), interferon and immune responses (3 papers) and Immune Cell Function and Interaction (3 papers). Naomi S. Sprigg collaborates with scholars based in Australia, United Kingdom and Malaysia. Naomi S. Sprigg's co-authors include Nicos A. Nicola, Douglas J. Hilton, Warren S. Alexander, Donald Metcalf, Robyn Starr, Sandra E. Nicholson, Tracy A. Willson, Elizabeth M. Viney, Rachael T. Richardson and Emanuela Handman and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Naomi S. Sprigg

11 papers receiving 1.6k citations

Hit Papers

Twenty proteins containing a C-terminal SOCS box form fiv... 1998 2026 2007 2016 1998 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naomi S. Sprigg Australia 9 1.2k 933 546 288 188 11 1.7k
Ritsu Suzuki Japan 9 1.4k 1.2× 942 1.0× 599 1.1× 356 1.2× 227 1.2× 9 1.9k
Koh Yamamoto Japan 14 1.1k 0.9× 1.3k 1.4× 629 1.2× 162 0.6× 175 0.9× 32 2.2k
Z Zhong United States 9 799 0.7× 762 0.8× 698 1.3× 119 0.4× 155 0.8× 9 1.7k
Chan D. Chung United States 8 1.0k 0.9× 945 1.0× 1.1k 1.9× 138 0.5× 238 1.3× 8 2.0k
Seijiro Minamoto Japan 17 1.4k 1.2× 1.5k 1.6× 694 1.3× 268 0.9× 315 1.7× 30 2.6k
T Improta United States 8 1.3k 1.1× 1.2k 1.3× 623 1.1× 123 0.4× 246 1.3× 13 1.7k
T Kishimoto Japan 7 672 0.6× 554 0.6× 423 0.8× 88 0.3× 187 1.0× 14 1.2k
A.C. Larner United States 9 610 0.5× 668 0.7× 303 0.6× 63 0.2× 122 0.6× 9 1.1k
Mairead Commane United States 19 743 0.6× 847 0.9× 1.1k 2.0× 68 0.2× 594 3.2× 23 2.1k
Jürgen Sasse United Arab Emirates 10 501 0.4× 281 0.3× 491 0.9× 92 0.3× 91 0.5× 16 957

Countries citing papers authored by Naomi S. Sprigg

Since Specialization
Citations

This map shows the geographic impact of Naomi S. Sprigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naomi S. Sprigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naomi S. Sprigg more than expected).

Fields of papers citing papers by Naomi S. Sprigg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naomi S. Sprigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naomi S. Sprigg. The network helps show where Naomi S. Sprigg may publish in the future.

Co-authorship network of co-authors of Naomi S. Sprigg

This figure shows the co-authorship network connecting the top 25 collaborators of Naomi S. Sprigg. A scholar is included among the top collaborators of Naomi S. Sprigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naomi S. Sprigg. Naomi S. Sprigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2012). CSL362: A Monoclonal Antibody to Human Interleukin-3 Receptor (CD123), Optimized for NK Cell-Mediated Cytotoxicity of AML Stem Cells. Blood. 120(21). 3598–3598. 10 indexed citations
3.
O’Sullivan, Lynda A., Suzita Mohd Noor, Monique C. Trengove, et al.. (2011). Suppressor of Cytokine Signaling 1 Regulates Embryonic Myelopoiesis Independently of Its Effects on T Cell Development. The Journal of Immunology. 186(8). 4751–4761. 14 indexed citations
4.
Sprigg, Naomi S., et al.. (2008). Lineage commitment in mammary epithelium is regulated by type 2 cytokines and Stat6. Breast Cancer Research. 10(S2). 3 indexed citations
5.
Kolesnik, Tatiana B., Anjana Chakravorty, Tracy A. Willson, et al.. (2008). 352 Suppressor of cytokine signalling (SOCS)-5 regulates IL-4 activity via interaction with the IL-4 receptor and inhibition of JAK1 kinase activity. Cytokine. 43(3). 327–327. 1 indexed citations
6.
Khaled, Walid T., Eliot Read, Sandra E. Nicholson, et al.. (2007). The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development. 134(15). 2739–2750. 102 indexed citations
7.
Babon, Jeffrey J., Edward J. McManus, Shenggen Yao, et al.. (2006). The Structure of SOCS3 Reveals the Basis of the Extended SH2 Domain Function and Identifies an Unstructured Insertion That Regulates Stability. Molecular Cell. 22(2). 205–216. 134 indexed citations
8.
Masters, Seth L., Kirsten R. Palmer, William Stevenson, et al.. (2005). Genetic Deletion of Murine SPRY Domain-Containing SOCS Box Protein 2 (SSB-2) Results in Very Mild Thrombocytopenia. Molecular and Cellular Biology. 25(13). 5639–5647. 15 indexed citations
9.
Nicholson, Sandra E., Donald Metcalf, Naomi S. Sprigg, et al.. (2005). Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling. Proceedings of the National Academy of Sciences. 102(7). 2328–2333. 78 indexed citations
10.
Alexander, Warren S., Robyn Starr, Clare L. Scott, et al.. (1999). SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine. Cell. 98(5). 597–608. 635 indexed citations breakdown →
11.
Hilton, Douglas J., Rachael T. Richardson, Warren S. Alexander, et al.. (1998). Twenty proteins containing a C-terminal SOCS box form five structural classes. Proceedings of the National Academy of Sciences. 95(1). 114–119. 638 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026